{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:07:48Z","timestamp":1787062068471,"version":"build-2736575974"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Zambon Company S.P.A"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40122-025-00735-5","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:22:42Z","timestamp":1745396562000},"page":"891-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Benefits of Ibuprofen Arginine: A Narrative Review"],"prefix":"10.1007","volume":"14","author":[{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Perez-Cajaraville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Maria Michele","family":"Fornasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3822-2923","authenticated-orcid":false,"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"9","key":"735_CR1","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja SN, Carr DB, Cohen M, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976\u201382. https:\/\/doi.org\/10.1097\/j.pain.0000000000001939.","journal-title":"Pain"},{"issue":"1","key":"735_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/j.pain.0000000000001390","volume":"160","author":"M Nicholas","year":"2019","unstructured":"Nicholas M, Vlaeyen JWS, Rief W, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160(1):28\u201337. https:\/\/doi.org\/10.1097\/j.pain.0000000000001390.","journal-title":"Pain"},{"issue":"1","key":"735_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/j.pain.0000000000001389","volume":"160","author":"S Perrot","year":"2019","unstructured":"Perrot S, Cohen M, Barke A, Korwisi B, Rief W, Treede RD. The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain. Pain. 2019;160(1):77\u201382. https:\/\/doi.org\/10.1097\/j.pain.0000000000001389.","journal-title":"Pain"},{"issue":"11","key":"735_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","volume":"16","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020;16(11):645\u201360. https:\/\/doi.org\/10.1038\/s41584-020-00506-w.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"735_CR5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/microorganisms10061084","volume":"10","author":"PHS Nunes","year":"2022","unstructured":"Nunes PHS, Valiatti TB, Santos ACDM, et al. Evaluation of the pathogenic potential of Escherichia coli strains isolated from eye Infections. Microorganisms. 2022;10(6):1084. https:\/\/doi.org\/10.3390\/microorganisms10061084.","journal-title":"Microorganisms."},{"issue":"6","key":"735_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","volume":"156","author":"RD Treede","year":"2015","unstructured":"Treede RD, Rief W, Barke A, et al. A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003\u20137. https:\/\/doi.org\/10.1097\/j.pain.0000000000000160.","journal-title":"Pain"},{"issue":"1","key":"735_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","volume":"160","author":"J Scholz","year":"2019","unstructured":"Scholz J, Finnerup NB, Attal N, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019;160(1):53\u20139. https:\/\/doi.org\/10.1097\/j.pain.0000000000001365.","journal-title":"Pain"},{"issue":"1","key":"735_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","volume":"160","author":"RD Treede","year":"2019","unstructured":"Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11). Pain. 2019;160(1):19\u201327. https:\/\/doi.org\/10.1097\/j.pain.0000000000001384.","journal-title":"Pain"},{"key":"735_CR9","unstructured":"Trung Ngo VH, Bajaj T. Ibuprofen continuing education activity. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542299\/."},{"key":"735_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/JPR.S280571","volume":"14","author":"JP Cajaraville","year":"2021","unstructured":"Cajaraville JP. Ibuprofen arginate for rapid-onset pain relief in daily practice: a review of its use in different pain conditions. J Pain Res. 2021;14:117\u201326. https:\/\/doi.org\/10.2147\/JPR.S280571.","journal-title":"J Pain Res"},{"issue":"2","key":"735_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000446151","volume":"7","author":"S Calafiore","year":"2016","unstructured":"Calafiore S, Perdicchi A, Scuderi G, Contestabile MT, Abdolrahimzadeh S, Recupero SM. Glaucoma management in carotid cavernous fistula. Case Rep Ophthalmol. 2016;7(2):296\u2013302. https:\/\/doi.org\/10.1159\/000446151.","journal-title":"Case Rep Ophthalmol"},{"key":"735_CR12","unstructured":"Fenske JN, Berland DW, Schneiderhan J, et al. Ambulatory pain management guideline team leads. 2021. http:\/\/michmed-clinical.policystat.com\/policy\/7109483\/."},{"issue":"6","key":"735_CR13","doi-asserted-by":"publisher","first-page":"E2216482","DOI":"10.1001\/jamanetworkopen.2022.16482","volume":"5","author":"SA Eucker","year":"2022","unstructured":"Eucker SA, Knisely MR, Simon C. Nonopioid treatments for chronic pain-integrating multimodal biopsychosocial approaches to pain management. JAMA Netw Open. 2022;5(6):E2216482. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.16482.","journal-title":"JAMA Netw Open"},{"issue":"22","key":"735_CR14","doi-asserted-by":"publisher","first-page":"6957","DOI":"10.3390\/jcm12226957","volume":"12","author":"K Themelis","year":"2023","unstructured":"Themelis K, Tang NKY. The management of chronic pain: re-centring person-centred care. J Clin Med. 2023;12(22):6957. https:\/\/doi.org\/10.3390\/jcm12226957.","journal-title":"J Clin Med"},{"key":"735_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00044011-200424070-00002","volume":"24","author":"C Castelo-Branco","year":"2004","unstructured":"Castelo-Branco C, Casals G, Haya J, Cancelo J, Manasanch J. Efficacy and safety of ibuprofen arginine in the treatment of primary dysmenorrhoea. Clin Drug Investig. 2004;24:385\u201393.","journal-title":"Clin Drug Investig"},{"key":"735_CR16","unstructured":"Moote CA. Ibuprofen arginine in the management of pain a review, vol. 1."},{"key":"735_CR17","unstructured":"Mart\u00edn Calero MJ, Jim\u00e9nez MD, Alarc\u00f3n De La Lastra C, La Casa C, Herrer\u00edas JM, Bruseghini L, Esteras A, Motilva V. Protective effect of L-arginine against ibuprofen-induced gastric injury in rats. vol 3. 1997. www.bl.uk."},{"key":"735_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019. https:\/\/doi.org\/10.1186\/s41073-019-0064-8.","journal-title":"Res Integr Peer Rev"},{"issue":"1","key":"735_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.berh.2015.04.022","volume":"29","author":"KR Ambrose","year":"2015","unstructured":"Ambrose KR, Golightly YM. Physical exercise as non-pharmacological treatment of chronic pain: why and when. Best Pract Res Clin Rheumatol. 2015;29(1):120\u201330. https:\/\/doi.org\/10.1016\/j.berh.2015.04.022.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"735_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23999","author":"Y Ishida","year":"2022","unstructured":"Ishida Y, Okada T, Kobayashi T, Funatsu K, Uchino H. Pain management of acute and chronic postoperative pain. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.23999. (Published online April 10, 2022).","journal-title":"Cureus"},{"issue":"5","key":"735_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/00325481.2016.1188319","volume":"128","author":"S Stanos","year":"2016","unstructured":"Stanos S, Brodsky M, Argoff C, et al. Rethinking chronic pain in a primary care setting. Postgrad Med. 2016;128(5):502\u201315. https:\/\/doi.org\/10.1080\/00325481.2016.1188319.","journal-title":"Postgrad Med"},{"key":"735_CR22","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.5152\/eurasianjmed.2022.22307","volume":"54","author":"SG Kose","year":"2022","unstructured":"Kose SG, Kose HC, Celikel F, et al. Chronic pain: an update of clinical practices and advances in chronic pain management. Eurasian Jo Med. 2022;54:S57\u201361. https:\/\/doi.org\/10.5152\/eurasianjmed.2022.22307.","journal-title":"Eurasian Jo Med"},{"key":"735_CR23","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","volume":"397","author":"MA Fitzcharles","year":"2021","unstructured":"Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, H\u00e4user W. Chronic pain 2 nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021;397:2098\u2013110.","journal-title":"Lancet"},{"issue":"8","key":"735_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9(8):807\u201319. https:\/\/doi.org\/10.1016\/S1474-4422(10)70143-5.","journal-title":"Lancet Neurol"},{"issue":"12","key":"735_CR25","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1080\/03007995.2020.1832058","volume":"36","author":"R Freynhagen","year":"2020","unstructured":"Freynhagen R, Rey R, Argoff C. When to consider \u201cmixed pain\u201d? The right questions can make a difference! Curr Med Res Opin. 2020;36(12):2037\u201346. https:\/\/doi.org\/10.1080\/03007995.2020.1832058.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"735_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.22270\/jddt.v14i3.6451","volume":"14","author":"MDR Guill\u00e9n-N\u00fa\u00f1ez","year":"2024","unstructured":"Guill\u00e9n-N\u00fa\u00f1ez MDR, Ju\u00e1rez-Lemus AM, Hern\u00e1ndez-Porras BC, Hern\u00e1ndez-Rodr\u00edguez D. Current perspective in mixed pain. J Drug Deliv Ther. 2024;14(3):170\u20133. https:\/\/doi.org\/10.22270\/jddt.v14i3.6451.","journal-title":"J Drug Deliv Ther"},{"key":"735_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0304-3959(81)90091-9","volume":"10","author":"W Fordyce","year":"1981","unstructured":"Fordyce W, McMahon R, Rainwater G, et al. Pain complaint-exercise performance relationship in chronic pain. Pain. 1981;10:311\u201321.","journal-title":"Pain"},{"key":"735_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-981-15-1792-1_16","volume-title":"Advances in experimental medicine and biology","author":"A Borisovskaya","year":"2020","unstructured":"Borisovskaya A, Chmelik E, Karnik A. Exercise and chronic pain. In: Advances in experimental medicine and biology, vol. 1228. Singapore: Springer; 2020. p. 233\u201353. https:\/\/doi.org\/10.1007\/978-981-15-1792-1_16."},{"issue":"2","key":"735_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3344\/kjp.23080","volume":"36","author":"BR Kim","year":"2023","unstructured":"Kim BR, Yoon SH, Lee HJ. Practical strategies for the prevention and management of chronic postsurgical pain. Korean J Pain. 2023;36(2):149\u201362. https:\/\/doi.org\/10.3344\/kjp.23080.","journal-title":"Korean J Pain"},{"key":"735_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.9734\/bpi\/namms\/v8\/10236F","volume":"8","author":"BA Bulbulia","year":"2023","unstructured":"Bulbulia BA, Bulbulia A. A brief overview on peri-operative pain management and chronic pain syndromes. New Adv Med Med Sci. 2023;8:84\u201394. https:\/\/doi.org\/10.9734\/bpi\/namms\/v8\/10236F.","journal-title":"New Adv Med Med Sci"},{"issue":"6","key":"735_CR31","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/1756-185X.14583","volume":"26","author":"BI Coskun","year":"2023","unstructured":"Coskun BI. Are non-steroidal anti-inflammatory drugs safe and effective in patients with acute gout? A Cochrane review summary with commentary. Int J Rheum Dis. 2023;26(6):1178\u201382. https:\/\/doi.org\/10.1111\/1756-185X.14583.","journal-title":"Int J Rheum Dis"},{"issue":"8","key":"735_CR32","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1097\/j.pain.0000000000001950","volume":"161","author":"DJ Clauw","year":"2020","unstructured":"Clauw DJ, H\u00e4user W, Cohen SP, Fitzcharles MA. Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. 2020;161(8):1694\u20137. https:\/\/doi.org\/10.1097\/j.pain.0000000000001950.","journal-title":"Pain"},{"issue":"1","key":"735_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.37897\/RJP.2019.1.4","volume":"68","author":"S Negres","year":"2019","unstructured":"Negres S. Ibuprofen, a drug used in pain, inflammation and fever. Roman J Pediatr. 2019;68(1):18\u201321. https:\/\/doi.org\/10.37897\/RJP.2019.1.4.","journal-title":"Roman J Pediatr"},{"key":"735_CR34","doi-asserted-by":"publisher","unstructured":"Joseph GV, Pascal VP, Paladini DA, et al. ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review. https:\/\/doi.org\/10.6084\/m9.figshare.10075727.","DOI":"10.6084\/m9.figshare.10075727"},{"key":"735_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000396.pub3","author":"PDDM Roelofs","year":"2008","unstructured":"Roelofs PDDM, Deyo RA, Koes BW, Scholten RJPM, Van Tulder MW. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008. https:\/\/doi.org\/10.1002\/14651858.CD000396.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"735_CR36","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/ejp.649","volume":"19","author":"RA Moore","year":"2015","unstructured":"Moore RA, Derry S, Wiffen PJ, Straube S, Aldington DJ. Overview review: comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions. Eur J Pain (United Kingdom). 2015;19(9):1213\u201323. https:\/\/doi.org\/10.1002\/ejp.649.","journal-title":"Eur J Pain (United Kingdom)"},{"issue":"6","key":"735_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10787-009-0016-x","volume":"17","author":"KD Rainsford","year":"2009","unstructured":"Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17(6):275\u2013342. https:\/\/doi.org\/10.1007\/s10787-009-0016-x.","journal-title":"Inflammopharmacology"},{"key":"735_CR38","unstructured":"Huang T, Panjeton GD. Types of pain. https:\/\/www.openanesthesia.org\/keywords\/types-of-pain\/."},{"issue":"4","key":"735_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","volume":"10","author":"H Breivik","year":"2006","unstructured":"Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287. https:\/\/doi.org\/10.1016\/j.ejpain.2005.06.009.","journal-title":"Eur J Pain"},{"key":"735_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.2","author":"L Colloca","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017. https:\/\/doi.org\/10.1038\/nrdp.2017.2.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"735_CR41","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s40520-018-1061-3","volume":"31","author":"S Thapa","year":"2019","unstructured":"Thapa S, Shmerling RH, Bean JF, Cai Y, Leveille SG. Chronic multisite pain: evaluation of a new geriatric syndrome. Aging Clin Exp Res. 2019;31(8):1129\u201337. https:\/\/doi.org\/10.1007\/s40520-018-1061-3.","journal-title":"Aging Clin Exp Res"},{"key":"735_CR42","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2147\/JPR.S192755","volume":"12","author":"KA Butera","year":"2019","unstructured":"Butera KA, Roff SR, Buford TW, Cruz-Almeida Y. The impact of multisite pain on functional outcomes in older adults: biopsychosocial considerations. J Pain Res. 2019;12:1115\u201325. https:\/\/doi.org\/10.2147\/JPR.S192755.","journal-title":"J Pain Res"},{"issue":"645","key":"735_CR43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3399\/bjgp16X684433","volume":"66","author":"A Davis","year":"2016","unstructured":"Davis A, Robson J. The dangers of NSAIDs: look both ways. Br J Gen Pract. 2016;66(645):172\u20133. https:\/\/doi.org\/10.3399\/bjgp16X684433.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"735_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/aos.13949","volume":"97","author":"K Tawfique","year":"2019","unstructured":"Tawfique K, Khademi P, Qu\u00e9rat L, Khadamy J, Chen E. Comparison between 90-degree and 360-degree selective laser trabeculoplasty (SLT): a 2-year follow-up. Acta Ophthalmol. 2019;97(4):427\u20139. https:\/\/doi.org\/10.1111\/aos.13949.","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"735_CR45","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1007\/s11096-018-0598-8","volume":"40","author":"S Modig","year":"2018","unstructured":"Modig S, Elmst\u00e5hl S. Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population. Int J Clin Pharm. 2018;40(4):870\u20137. https:\/\/doi.org\/10.1007\/s11096-018-0598-8.","journal-title":"Int J Clin Pharm"},{"key":"735_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-017-0078-7","author":"K Shibata","year":"2017","unstructured":"Shibata K, Akagi Y, Nozawa N, Shimomura H, Aoyama T. Influence of nonsteroidal anti-inflammatory drugs on aspirin\u2019s antiplatelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction. J Pharm Health Care Sci. 2017. https:\/\/doi.org\/10.1186\/s40780-017-0078-7.","journal-title":"J Pharm Health Care Sci"},{"issue":"4","key":"735_CR47","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/microorganisms12040649","volume":"12","author":"L Drago","year":"2024","unstructured":"Drago L. Topical antibiotic therapy in the ocular environment: the benefits of using moxifloxacin eyedrops. Microorganisms. 2024;12(4):649. https:\/\/doi.org\/10.3390\/microorganisms12040649.","journal-title":"Microorganisms"},{"issue":"2","key":"735_CR48","first-page":"77","volume":"1","author":"DM Cummings","year":"1988","unstructured":"Cummings DM, Amadio P Jr, Nettler S, Freedman M. Office-based evaluation of renal function in elderly patients receiving nonsteroidal anti-inflammatory drugs. J Am Board Fam Pract. 1988;1(2):77\u201380.","journal-title":"J Am Board Fam Pract"},{"key":"735_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/clpt.1986.193","volume":"40","author":"SL Bonney","year":"1986","unstructured":"Bonney SL, Northington RS, Hedrich DA, Walker BR. Renal safety of two analgesics used over the counter: ibuprofen and aspirin. Clin Pharmacol Ther. 1986;40:373\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"735_CR50","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/pharmaceutics14061120","volume":"14","author":"N Ferri","year":"2022","unstructured":"Ferri N, Colombo E, Tenconi M, Baldessin L, Corsini A. Drug\u2013drug interactions of direct oral anticoagulants (DOACs): from pharmacological to clinical practice. Pharmaceutics. 2022;14(6):1120. https:\/\/doi.org\/10.3390\/pharmaceutics14061120.","journal-title":"Pharmaceutics"},{"issue":"3","key":"735_CR51","doi-asserted-by":"publisher","first-page":"E241342","DOI":"10.1001\/jamanetworkopen.2024.1342","volume":"7","author":"TS Anderson","year":"2024","unstructured":"Anderson TS, Wang BX, Lindenberg JH, Herzig SJ, Berens DM, Schonberg MA. Older adult and primary care practitioner perspectives on using, prescribing, and deprescribing opioids for chronic pain. JAMA Netw Open. 2024;7(3):E241342. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.1342.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"735_CR52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jalz.2011.03.012","volume":"8","author":"S C\u00f4t\u00e9","year":"2012","unstructured":"C\u00f4t\u00e9 S, Carmichael PH, Verreault R, Lindsay J, Lefebvre J, Laurin D. Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement. 2012;8(3):219\u201326. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.012.","journal-title":"Alzheimers Dement"},{"key":"735_CR53","doi-asserted-by":"publisher","DOI":"10.2174\/157488410793352012","author":"D Cattaneo","year":"2010","unstructured":"Cattaneo D, Clementi E. Clinical pharmacokinetics of ibuprofen arginine. Curr Clin Pharmacol. 2010. https:\/\/doi.org\/10.2174\/157488410793352012.","journal-title":"Curr Clin Pharmacol"},{"issue":"6","key":"735_CR54","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2165\/00003495-199448060-00007","volume":"48","author":"CR Lee","year":"1994","unstructured":"Lee CR, Balfour JA. Piroxicam-\u03b2-cyclodextrin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states. Drugs. 1994;48(6):907\u201329. https:\/\/doi.org\/10.2165\/00003495-199448060-00007.","journal-title":"Drugs"},{"issue":"6","key":"735_CR55","first-page":"923","volume":"16","author":"D Jung","year":"1994","unstructured":"Jung D, Schwartz KE. Steady-state pharmacokinetics of enteric-coated naproxen tablets compared with standard naproxen tablets. Clin Ther. 1994;16(6):923\u20139.","journal-title":"Clin Ther"},{"issue":"1","key":"735_CR56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/j.1552-4604.1990.tb03442.x","volume":"30","author":"NS Jallad","year":"1990","unstructured":"Jallad NS, Garg DC, Martinez JJ, Mroszczak EJ, Weidler DJ. Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly. J Clin Pharmacol. 1990;30(1):76\u201381. https:\/\/doi.org\/10.1002\/j.1552-4604.1990.tb03442.x.","journal-title":"J Clin Pharmacol"},{"key":"735_CR57","doi-asserted-by":"publisher","unstructured":"Ben\u00edtez-del-Castillo J, D\u00edaz-Valle D, Geg\u00fandez-Fern\u00e1ndez J, Rodriguez-U\u00f1a I, Ba\u00f1eros-Rojas P, Jim\u00e9nez C. Systemic antibiotics with ophthalmic clinical usefulness. In: Ocular pharmacotherapy. Jaypee Brothers Medical Publishers (P) Ltd.; 2017. pp. 91\u201391. https:\/\/doi.org\/10.5005\/jp\/books\/12924_8.","DOI":"10.5005\/jp\/books\/12924_8"},{"key":"735_CR58","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1023\/B:DDAS.0000042261.22387.06","volume":"49","author":"S Gallego-Sand\u00edn","year":"2004","unstructured":"Gallego-Sand\u00edn S, Novalbos J, Rosado A, et al. Effect of ibuprofen on cyclooxygenase and nitric oxide synthase of gastric mucosa: correlation with endoscopic lesions and adverse reactions. Dig Dis Sci. 2004;49:1538\u201344.","journal-title":"Dig Dis Sci"},{"key":"735_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/783235","volume":"2013","author":"M Lipnik-Stangelj","year":"2013","unstructured":"Lipnik-Stangelj M. Mediators of inflammation as targets for chronic pain treatment. Mediat Inflamm. 2013;2013:1\u20133. https:\/\/doi.org\/10.1155\/2013\/783235.","journal-title":"Mediat Inflamm."},{"issue":"6","key":"735_CR60","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.mehy.2007.06.033","volume":"69","author":"S Omoigui","year":"2007","unstructured":"Omoigui S. The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3\u2014inflammatory profile of pain syndromes. Med Hypotheses. 2007;69(6):1169\u201378. https:\/\/doi.org\/10.1016\/j.mehy.2007.06.033.","journal-title":"Med Hypotheses"},{"key":"735_CR61","doi-asserted-by":"publisher","DOI":"10.1177\/17448069231178176","author":"XX Fang","year":"2023","unstructured":"Fang XX, Zhai MN, Zhu M, et al. Inflammation in pathogenesis of chronic pain: foe and friend. Mol Pain. 2023. https:\/\/doi.org\/10.1177\/17448069231178176.","journal-title":"Mol Pain"},{"issue":"6","key":"735_CR62","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.jtha.2024.03.006","volume":"22","author":"R Vaja","year":"2024","unstructured":"Vaja R, Lopes-Pires M, Shala F, et al. l-Arginine supplementation protects against thrombosis and renal dysfunction in mice treated with the cyclooxygenase-2 inhibitor parecoxib. J Thromb Haemost. 2024;22(6):1798\u2013801. https:\/\/doi.org\/10.1016\/j.jtha.2024.03.006.","journal-title":"J Thromb Haemost"},{"key":"735_CR63","first-page":"1072","volume":"24","author":"P Black","year":"2002","unstructured":"Black P, Max MB, Desjardins P, Norwood T, Ardia A, Pallotta T. A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental. Pain. 2002;24:1072\u201389.","journal-title":"Pain"},{"issue":"5","key":"735_CR64","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1600-051X.2006.00918.x","volume":"33","author":"DA Ettlin","year":"2006","unstructured":"Ettlin DA, Ettlin A, Bless K, et al. Ibuprofen arginine for pain control during scaling and root planing: a randomized, triple-blind trial. J Clin Periodontol. 2006;33(5):345\u201350. https:\/\/doi.org\/10.1111\/j.1600-051X.2006.00918.x.","journal-title":"J Clin Periodontol"},{"issue":"8","key":"735_CR65","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/009127002401102821","volume":"42","author":"DR Mehlisch","year":"2002","unstructured":"Mehlisch DR, Ardia A, Pallotta T. A controlled comparative study of ibuprofen arginate versus conventional ibuprofen in the treatment of postoperative dental pain. J Clin Pharmacol. 2002;42(8):904\u201311. https:\/\/doi.org\/10.1177\/009127002401102821.","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"735_CR66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00228-002-0491-0","volume":"58","author":"P Desjardins","year":"2002","unstructured":"Desjardins P, Black P, Papageorge M, et al. Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofen. Eur J Clin Pharmacol. 2002;58(6):387\u201394. https:\/\/doi.org\/10.1007\/s00228-002-0491-0.","journal-title":"Eur J Clin Pharmacol"},{"key":"735_CR67","doi-asserted-by":"publisher","first-page":"104875","DOI":"10.1016\/j.jdent.2024.104875","volume":"142","author":"D Hortkoff","year":"2024","unstructured":"Hortkoff D, da Silva KL, Farago PV, Gomes JC, Reis A, Gomes GM. Effect of topical application of ibuprofen\/arginine on the in-office bleaching-induced tooth sensitivity: a randomized, triple-blind controlled trial. J Dent. 2024;142:104875. https:\/\/doi.org\/10.1016\/j.jdent.2024.104875.","journal-title":"J Dent"},{"key":"735_CR68","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2165\/00044011-199714040-00005","volume":"14","author":"C De","year":"1997","unstructured":"De C, Rivero M, Araujo CG, et al. Comparative efficacy of oral ibuprofen-arginine, intramuscular magnesic dipyrone and placebo in patients with postoperative pain following total hip replacement. Clin Drug Investig. 1997;14:276\u201385.","journal-title":"Clin Drug Investig"},{"key":"735_CR69","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/00003643-199609000-00013","volume":"13","author":"M Mansfield","year":"1996","unstructured":"Mansfield M, Firth F, Glynn C, Kinsella J. A comparison of ibuprofen arginine with morphine sulphate for pain relief after orthopaedic surgery. Eur J Anaesthesiol. 1996;13:492\u20137.","journal-title":"Eur J Anaesthesiol"},{"key":"735_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00044011-199600111-00005","volume":"11","author":"B Pagnoni","year":"1996","unstructured":"Pagnoni B, Vignalu M, Colella S, Monopo R, Tiengo M. Comparative efficacy of oral ibuprofen arginine and intramuscular ketorolac in patients with postcaesarean section pain. Clin Drug Investig. 1996;11:15\u201321.","journal-title":"Clin Drug Investig"},{"key":"735_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/00044011-199600111-00007","volume":"11","author":"B Pagnoni","year":"1996","unstructured":"Pagnoni B, Ravanelli A, Degradi L, Rossi R, Tiengo M. Clinical efficacy of ibuprofen arginine in the management of postoperative pain associated with suction termination of pregnancy a double-blind placebo-controlled study. Clin Drug Investig. 1996;11:27\u201335.","journal-title":"Clin Drug Investig"},{"issue":"4","key":"735_CR72","first-page":"556","volume":"42","author":"N Ceppi Monti","year":"1992","unstructured":"Ceppi Monti N, Gazzaniga A, Gianesello V, Stroppolo F, Lodola E. Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen. Arzneimittelforschung. 1992;42(4):556\u20139.","journal-title":"Arzneimittelforschung"},{"key":"735_CR73","unstructured":"Laveneziana D, Speranza R, Raulli P, Paredi G. Suppl. I) 22\u00b720. LQQ\u00a2 I I 73\u20132563\/96\/00Jl."},{"key":"735_CR74","unstructured":"Final Study Report IA-US 09. A randomized, parallel, double-blind, double-dummy, placebo-controlled study to determine the onset of action of PHZ 136 and Motrin\u00ae IB in patients with acute muscle-contraction (tension) headache. 1997 (unpublished data)."},{"issue":"3","key":"735_CR75","first-page":"145","volume":"18","author":"G Sandrini","year":"1998","unstructured":"Sandrini G, Franchini S, Lanfranchi S, Granella F, Manzoni GC, Nappi G. Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks. Int J Clin Pharmacol Res. 1998;18(3):145\u201350.","journal-title":"Int J Clin Pharmacol Res"},{"issue":"6","key":"735_CR76","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0011-393X(03)00104-8","volume":"64","author":"DR Mehlisch","year":"2003","unstructured":"Mehlisch DR, Ardia A, Pallotta T. Analgesia with ibuprofen arginate versus conventional ibuprofen for patients with dysmenorrhea: a crossover trial. Curr Ther Res Clin Exp. 2003;64(6):327\u201337. https:\/\/doi.org\/10.1016\/S0011-393X(03)00104-8.","journal-title":"Curr Ther Res Clin Exp"},{"key":"735_CR77","unstructured":"Final Study Report IA-US 13. A randomized, crossover, double-blind, placebo-controlled study to determine the onset of action of PHZ 136 and Motrin\u00ae IB in patients with lower abdominal cramp-like menstrual pain due to primary dysmenorrhea. 1997 (unpublished data)."},{"key":"735_CR78","unstructured":"Final Study Report IA-US-12. A Randomized, crossover, double-blind, placebo-controlled study to determine the onset of action of PHZ 136 and Motrin\u00ae IB in patients with lower abdominal cramp-like menstrual pain due to primary dysmenorrhea. 1996 (unpublished data)."},{"key":"735_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-024-05765-5","author":"JP de Oliveira","year":"2024","unstructured":"de Oliveira JP, de Alencar AHG, Estrela CB, Decurcio DA, Estrela CRA, Estrela C. Comparative effectiveness of preemptive administration of ibuprofen and ibuprofen-arginine on the anesthetic success of inferior alveolar nerve block in teeth with symptomatic irreversible pulpitis\u2014a double-blind randomized clinical trial. Clin Oral Investig. 2024. https:\/\/doi.org\/10.1007\/s00784-024-05765-5.","journal-title":"Clin Oral Investig"},{"issue":"Suppl 1","key":"735_CR80","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00044011-199600111-00008","volume":"11","author":"G Borea","year":"1996","unstructured":"Borea G, Monopoli R, Colantoni A. Ibuprofen arginine vs naproxen sodium as prophylactic oral treatment of pain due to dental surgery. Clin Drug Investig. 1996;11(Suppl 1):33\u201340. https:\/\/doi.org\/10.2165\/00044011-199600111-00008.","journal-title":"Clin Drug Investig"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00735-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-025-00735-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00735-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T05:23:07Z","timestamp":1747459387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-025-00735-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1007\/s40122-025-00735-5","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Giustino Varrassi received honoraria from Abbott, Agave, Berlin-Chemie, Menarini, Zambon, and several other companies, as a consultant or member of speakers\u2019 bureau and advisory board, during the last 24 months. Giustino Varrassi is an Editor-in-Chief of Pain and Therapy. Giustino Varrassi was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. In the last 2\u00a0years, Diego Fornasari had relationships as a component of the speakers\u2019 bureau, consultant and member of advisory boards with the following companies: Abiogen, Alfasigma, Angelini, Agave, Chiesi Daiichi-Sankyo, Grunenthal, Lundbeck, Janssen, Molteni, Sandoz, Samsung, Sobi, SPA, Viatris, Zambon. Serge Perrot received fees for advisory board participation and consultancy from Sanofi, GSK, Menarini, Zambon. Franco Radaelli and Juan Perez Cajaraville declare no competing financial interests. Piercarlo Sarzi Puttini received fees for advisory board participation and consultancy by Novartis, Johnson and Johnson, Eli Lilly, UCB, Viatris, Alfasigma. Piercarlo Sarzi Puttini was also supported and funded by the Italian Ministry of Health, \u201cRicerca Corrente\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}